✦ LIBER ✦

Imatinib mesylate treatment of nephrogenic systemic fibrosis

✍ Scribed by Jonathan Kay; Whitney A. High

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 364 KB
Volume: 58
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.23696

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nephrogenic systemic fibrosis: Clinical

Nephrogenic systemic fibrosis: Clinical spectrum of disease

✍ Michael Mayr; Felix Burkhalter; Georg Bongartz 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 374 KB

## Abstract Nephrogenic systemic fibrosis (NSF) is a rare systemic fibrosing disorder that primarily affects the skin and the subcutaneous structures. Also, there are reports of involvement of deeper structures and organs in the human body, but the confirmation of systemic involvement is complicate

Imatinib mesylate in the treatment of sy

Imatinib mesylate in the treatment of systemic mastocytosis : A phase II trial

✍ Helga J. Droogendijk; Hanneke J. C. Kluin-Nelemans; Jaap J. van Doormaal; Arnold 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB

Nephrogenic systemic fibrosis: Summary o

Nephrogenic systemic fibrosis: Summary of the special symposium

✍ Georg Bongartz; Walter Kucharczyk 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB

THE PREPARATIONS FOR THE scientific and educational programs of the Joint Annual Meeting of the ISMRM and the ESMRMB typically begin one and a half to two years prior to the meeting date. During the preparation phase of the 2007 meeting in Berlin, Thomas Grobner and others described a possible relat

Incidence of nephrogenic systemic fibros

Incidence of nephrogenic systemic fibrosis at Chinese PLA General Hospital

✍ Zhitong Zou; Lin Ma; Hengjin Li 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

## Abstract Magnetic resonance imaging (MRI), dermatology, and dermatopathology records were searched to determine the incidence of nephrogenic systemic fibrosis (NSF) at a large military hospital in China. Over the past 3.7 years, gadolinium‐based contrast agent (GBCA)‐enhanced MRI was performed w

Treatment with imatinib prevents fibrosi

Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis

✍ Alfiya Akhmetshina; Paulius Venalis; Clara Dees; Nicole Busch; Jochen Zwerina; G 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 295 KB 👁 1 views

Extracorporeal photopheresis improves ne

Extracorporeal photopheresis improves nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: Three case reports and review of literature

✍ Kiran Mathur; Scott Morris; Chris Deighan; Rachel Green; Kenneth William Douglas 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB

## Abstract Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis (NFD/NSF) is a recently recognized systemic fibrosing disorder that develops in the context of renal insufficiency. Its predominant manifestation is severe cutaneous fibrosis, often causing disabling contractures of neighbor